Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
A variety of antibodies detect the antigen defined by the cluster designation group 15 (CD15). These antibodies have been reported to be helpful in the diagnosis of many different diseases including leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma, as well as aiding in the differential diagnosis between epithelial malignant mesothelioma and adenocarcinoma. In this review we describe the immunoreactivity of many of the CD15 antibodies, including MMA (Leu M1), anti-My1, C3D-1 (Dako-M1), VIM-D5, 1G10, MCS-1, anti-SSEA, and 3C4. The expression of the CD15 antigen in non-neoplastic human cells, leukemic cell lines and in neoplastic cells is reviewed.
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Jan 1, 1993
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.